Biopharma Daily Stock Updates - 02/03/21

Get BPIQ Pro and gain access to our database of over ~300 companies and ~1,200 drug assets. Featuring a fully searchable catalyst database. Try risk-free, no credit card required.

---

$XBI $161.07 -1% 📉

COVID:

$MRNA +4% Moderna Announces Amendment to Supply Agreement with Switzerland for an Additional 6 Million Doses of COVID-19 Vaccine Moderna

$IMNM +8% Abzena Selected by Immunome to Develop and Manufacture Antibody Cocktail for Immunome’s COVID-19 Antibody Based Treatment

$AZN -1% COVID-19 Vaccine AstraZeneca confirms 100% protection against severe disease, hospitalisation and death in the primary analysis of Phase III trials

PIPELINE:

$SIOX +2% Sio Gene Therapies Announces First Patient Dosed in Clinical Trial of AXO-AAV-GM2 in Patients with Tay-Sachs and Sandhoff Disease (GM2 Gangliosidosis)

$BCRX -2% BioCryst Announces FDA Approval of Supplemental New Drug Application for RAPIVAB® Expanding Patient Population to Include Children Six Months and Older

FINANCIAL:

$GWPH +45% Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating an Innovative, High-Growth, Global Biopharma Leader

$DRRX -11% DURECT Corporation Announces Proposed Offering of Common Stock

$RYTM - 1% Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering